Businesses are seeing budgets stretched in many ways, but, as Owain Thomas found, advisers who are creative with solutions could produce a windfall for themselves in the group critical illness market
A quite common and relatively benign condition often seen on insurance applications, Paul Gyseman discusses the insurability factors and the pathophysiology of this illness
Are we simply opposed to simple products? Nick Jones investigates the simplicity minefield.
This year, new EU legislation will be introduced making regular sight tests compulsory for any employee who drives while on company business. Jill Davies investigates who will fund the cost.
Governments across Europe are getting on board to help people stop smoking. Ross Campbell discusses nicotine replacement therapy's underwriting implications
The reform of the NHS is dominating many discussions in private healthcare circles, but Owain Thomas unearths another government initiative that could have a greater impact
The rise of bank-based distribution for many long-term insurance products led to the term ‘bancassurance'. But is bancassurance distribution ready for a rethink? Greg Becker investigates
With the NHS effectively withdrawing its level of support, are we veering towards a hybrid US model of healthcare? How will this shape employee benefits? Dr Peter Mills investigates.
The industry knows group risk benefits are valuable, but does anyone else? The sector needs an image boost to thrive, says Peter Fenner.
Several clients have come to me with queries about existing mortgage payment protection insurance (MPPI) and PPI policies. I don't have the time to read all the policy documentation, but given the current situation in the PPI market for Treating Customers...